Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

H. Rheinallt Parri, Caterina M. Hernandez, Kelly T. Dineley

Research output: Contribution to journalArticle

Abstract

Aberrant amyloid-ß peptide (Aß) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aß is bound to a7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the a7 nAChR-Aß interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.
LanguageEnglish
Pages931-942
Number of pages12
JournalBiochemical Pharmacology
Volume82
Issue number8
Early online date7 Jul 2011
DOIs
Publication statusPublished - 15 Oct 2011

Fingerprint

alpha7 Nicotinic Acetylcholine Receptor
Amyloid
Alzheimer Disease
Nicotinic Receptors
Peptides
Research
Brain
Therapeutics

Keywords

  • allosteric regulation
  • Alzheimer disease
  • amyloid beta-peptides
  • animals binding sites
  • cognition
  • humans
  • learning
  • memory
  • protein binding
  • nicotinic receptors
  • signal transduction
  • synaptic transmission

Cite this

Parri, H. Rheinallt ; Hernandez, Caterina M. ; Dineley, Kelly T. / Research update : alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. In: Biochemical Pharmacology. 2011 ; Vol. 82, No. 8. pp. 931-942.
@article{8e50b1ed2ec24649bdf7284eeb80a271,
title = "Research update: alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease",
abstract = "Aberrant amyloid-{\ss} peptide (A{\ss}) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that A{\ss} is bound to a7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the a7 nAChR-A{\ss} interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.",
keywords = "allosteric regulation, Alzheimer disease, amyloid beta-peptides, animals binding sites, cognition, humans, learning, memory, protein binding, nicotinic receptors, signal transduction, synaptic transmission",
author = "Parri, {H. Rheinallt} and Hernandez, {Caterina M.} and Dineley, {Kelly T.}",
note = "Copyright {\circledC} 2011 Elsevier Inc. All rights reserved.",
year = "2011",
month = "10",
day = "15",
doi = "10.1016/j.bcp.2011.06.039",
language = "English",
volume = "82",
pages = "931--942",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier",
number = "8",

}

Research update : alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. / Parri, H. Rheinallt; Hernandez, Caterina M.; Dineley, Kelly T.

In: Biochemical Pharmacology, Vol. 82, No. 8, 15.10.2011, p. 931-942.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Research update

T2 - Biochemical Pharmacology

AU - Parri, H. Rheinallt

AU - Hernandez, Caterina M.

AU - Dineley, Kelly T.

N1 - Copyright © 2011 Elsevier Inc. All rights reserved.

PY - 2011/10/15

Y1 - 2011/10/15

N2 - Aberrant amyloid-ß peptide (Aß) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aß is bound to a7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the a7 nAChR-Aß interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.

AB - Aberrant amyloid-ß peptide (Aß) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aß is bound to a7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the a7 nAChR-Aß interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.

KW - allosteric regulation

KW - Alzheimer disease

KW - amyloid beta-peptides

KW - animals binding sites

KW - cognition

KW - humans

KW - learning

KW - memory

KW - protein binding

KW - nicotinic receptors

KW - signal transduction

KW - synaptic transmission

UR - http://www.scopus.com/inward/record.url?scp=80052033738&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2011.06.039

DO - 10.1016/j.bcp.2011.06.039

M3 - Article

VL - 82

SP - 931

EP - 942

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 8

ER -